12:30:57 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-03-27 Kvartalsrapport 2024-Q3
2023-12-21 Kvartalsrapport 2024-Q2
2023-11-15 Extra Bolagsstämma 2024
2023-10-27 Årsstämma 2024
2023-10-13 Ordinarie utdelning PHI 0.00 SEK
2023-09-20 Kvartalsrapport 2024-Q1
2023-06-23 Bokslutskommuniké 2023
2023-05-09 Extra Bolagsstämma 2023
2023-03-28 Kvartalsrapport 2023-Q3
2022-12-21 Kvartalsrapport 2023-Q2
2022-10-31 Årsstämma 2023
2022-10-14 Ordinarie utdelning PHI 0.00 SEK
2022-09-29 Kvartalsrapport 2023-Q1
2022-06-29 Bokslutskommuniké 2022
2022-03-21 Kvartalsrapport 2022-Q3
2022-03-15 Extra Bolagsstämma 2022
2021-12-29 Kvartalsrapport 2022-Q2
2021-10-20 Extra Bolagsstämma 2021
2021-10-11 Ordinarie utdelning PHI 0.00 SEK
2021-09-29 Kvartalsrapport 2022-Q1
2021-06-24 Bokslutskommuniké 2021
2021-03-16 Kvartalsrapport 2021-Q3
2020-12-14 Kvartalsrapport 2021-Q2
2020-10-20 Årsstämma 2021
2020-10-15 Ordinarie utdelning PHI 0.00 SEK
2020-09-28 Kvartalsrapport 2021-Q1
2020-06-25 Bokslutskommuniké 2020
2020-03-12 Kvartalsrapport 2020-Q3
2019-12-17 Kvartalsrapport 2020-Q2
2019-10-16 Ordinarie utdelning PHI 0.00 SEK
2019-10-15 Årsstämma 2020
2018-09-27 Ordinarie utdelning PHI 0.00 SEK
2018-09-26 Årsstämma 2019
2018-06-18 Extra Bolagsstämma 2019
2018-06-12 Bokslutskommuniké 2018
2018-03-12 Kvartalsrapport 2018-Q3
2017-09-26 Ordinarie utdelning PHI 0.00 SEK
2017-09-25 Årsstämma 2018
2017-09-11 Kvartalsrapport 2018-Q1
2017-06-19 Bokslutskommuniké 2017
2017-03-13 Kvartalsrapport 2017-Q3
2017-01-01 Extra Bolagsstämma 2018
2016-11-30 Kvartalsrapport 2017-Q2
2016-09-06 Ordinarie utdelning PHI 0.00 SEK
2016-09-05 Kvartalsrapport 2017-Q1
2016-09-05 Årsstämma 2017
2016-06-13 Bokslutskommuniké 2016
2016-02-22 Kvartalsrapport 2016-Q3
2016-02-16 Extra Bolagsstämma 2017
2015-11-30 Kvartalsrapport 2016-Q2
2015-09-08 Ordinarie utdelning PHI 0.00 SEK
2015-09-07 Årsstämma 2016
2015-09-07 Kvartalsrapport 2016-Q1
2015-06-16 Bokslutskommuniké 2015
2015-03-16 Kvartalsrapport 2015-Q3
2014-12-01 Kvartalsrapport 2015-Q2
2014-10-07 Ordinarie utdelning PHI 0.00 SEK
2014-10-06 Kvartalsrapport 2015-Q1
2014-10-06 Årsstämma 2015
2014-06-30 Bokslutskommuniké 2014

Beskrivning

LandSverige
ListaSpotlight
SektorHälsovård
IndustriMedicinteknik
Phase Holographic Imaging PHI är verksamt inom medicinteknik. Bolaget utvecklar instrument och mjukvara för time-lapse cytometri. Produkterna används för kvantitativ långtidsanalys av levande cellers dynamik, särskilt av betydelse inom cancerforskning, samt vid behandling av inflammatoriska - samt autoimmuna sjukdomar. Produkterna säljs på global nivå via bolagets distributörer och störst närvaro återfinns inom Norden. Huvudkontoret ligger i Lund.
2023-04-24 11:10:47

Thursday, 27 April 2023, is the last day of trading in warrants of series TO 3, which were issued in connection with Phase Holographic Imaging PHI AB's ("PHI" or the "Company") rights issue of units that was announced on 22 February 2022. The exercise period runs until and including 2 May 2023.

Each warrant of series TO 3 entitles the holder to subscribe for one (1) new share in PHI at a price of SEK 3.78 per share during the exercise period that started on 11 April 2023 and runs until and including 2 May 2023.

For warrants not to expire worthless, warrant holders must subscribe for new shares, with the support of warrants, at 17:00 CEST on 2 May 2023, at the latest, alternatively sell warrants no later than on 27 April 2023.

For more information, including a more detailed description of PHI's operations as well as complete terms and conditions, please refer to the prospectus that was prepared in connection with the rights issue and published by the Company on 28 March 2023.  The prospectus is available on PHI's website (https://phiab.com/ir/). More information about the Company and the offer is also available on the websites of PHI (www.phiab.com), Sedermera Corporate Finance AB (www.sedermera.se) and Nordic Issuing AB (www.nordic-issuing.se). Complete terms and conditions for warrants of series TO 3 are available on the Company's website (www.phiab.com).

Important dates
  • 27 April 2023: Last day of trading in warrants

  • 2 May 2023: The exercise period ends

  • 4 May 2023: Planned communication of the outcome of the warrant exercise

  • 23 May 2023: Planned conversion of interim shares to ordinary shares

Advisors

In connection with the exercise of warrants of series TO 3, Sedermera Corporate Finance AB is acting as financial advisor, Markets & Corporate Law Nordic AB as legal advisor and Nordic Issuing AB as issuing agent. Shark Communication AB is assisting the Company with advice regarding communication.

For more information about the warrants of series TO 3, please contact:

Sedermera Corporate Finance AB
Phone: +46 40 615 14 10
E-mail: cf@sedermera.se (info@sedermera.se)
www.sedermera.se